š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
Anti-rejection medicines, also known as immunosuppressive drugs, are prescr...
Status
Completed
Location
Duke University Health System
Start Date
2018-07-30
Trial ID
NCT03504241
RATIONALE: Photopheresis treats the patient's blood with drugs and ultravio...
Status
Completed
Location
Mayo Clinic Scottsdale
Start Date
2006-10-24
Trial ID
NCT00045305
The purpose of this research study is to see if a study drug called Tociliz...
Status
Completed
Location
Cedars Sinai Medical Center (CACS)
Start Date
2018-12-20
Trial ID
NCT03644667
Treatments Being Tested
This is a randomized, multi-site, adaptive, open-label clinical trial compa...
Status
Terminated
Location
UCLA Medical Center: Division of Rheumatology
Start Date
2021-08-13
Trial ID
NCT05000216
Treatments Being Tested
Randomized prospective multi-center imaging study which investigates the im...
Status
Unknown
Location
University Hospital Zurich, Division of Cardiology
Start Date
2013-12
Trial ID
NCT02254668
Treatments Being Tested
The study is a Phase II clinical trial. Patients will receive intensity mod...
Status
Recruiting
Location
University of Illinois at Chicago
Start Date
2017-03-20
Trial ID
NCT03121001
The purpose of this study is look at the safety of: * Taking a specific co...
Status
Terminated
Location
University of California, San Francisco
Start Date
2014-12-17
Trial ID
NCT02188719
This trial seeks to describe the effect of withdrawal from mycophenolate mo...
Status
Terminated
Location
Cedars-Sinai Medical Center
Start Date
2013-11-20
Trial ID
NCT01946880
Treatments Being Tested
This study is being done to find out whether patients who receive a kidney ...
Status
Completed
Location
Mayo Clinic
Start Date
2007-01
Trial ID
NCT00587158
Treatments Being Tested
To demonstrate that cyclosporine-sparing immunosuppressions with the standa...
Status
Completed
Location
Multiple Locations
Start Date
2011-06
Trial ID
NCT01817322